Pre-earnings options volume in Iovance Biotherapeutics is normal with calls leading puts 3:1. Implied volatility suggests the market is anticipating a move near 12.1%, or $1.61, after results are released. Median move over the past eight quarters is 3.6%.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IOVA:
- Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024
- Iovance Biotherapeutics call volume above normal and directionally bullish
- Iovance Biotherapeutics to Present at Upcoming Conferences
- Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)